India's demand for COVID-19 drug remdesivir to fall, says Cipla
Posted by
www.biotecnika.org
Cipla was among the first companies in India to launch a generic
version of remdesivir, developed by U.S.-based Gilead Sciences, and as
of September had sold more than 300,000 vials across India.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indias-demand-for-covid-19-drug-remdesivir-to-fall-says-cipla/articleshow/80654578.cms
Subscribe to:
Post Comments (Atom)
Post a Comment